Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.450
+0.020 (0.58%)
At close: Mar 10, 2026, 4:00 PM EDT
3.423
-0.027 (-0.79%)
After-hours: Mar 10, 2026, 5:20 PM EDT

Apyx Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
31.7431.7443.6510.1930.87
Cash & Short-Term Investments
31.7431.7443.6510.1930.87
Cash Growth
-0.00%-27.29%328.30%-66.98%-26.35%
Accounts Receivable
16.7815.4814.0210.613.04
Other Receivables
---7.648.13
Total Trade Receivables
16.7815.4814.0218.2521.16
Inventory
8.67.569.9211.86.78
Other Current Assets
1.351.662.762.741.93
Total Current Assets
58.4756.4470.3642.9760.74
Net Property, Plant & Equipment
6.626.747.157.596.87
Other Long-Term Assets
1.751.661.731.221.11
Total Assets
66.8464.8479.2451.7868.72
Accounts Payable
3.062.622.712.672.63
Accrued Expenses
8.217.759.668.9310.29
Current Portion of Leases
0.430.360.370.250.29
Total Current Liabilities
11.710.7212.7411.8513.21
Long-Term Debt
34.8533.8933.19--
Long-Term Leases
4.064.524.950.540.02
Other Long-Term Liabilities
1.41.381.441.591.49
Total Long-Term Liabilities
40.3139.7939.582.131.51
Total Liabilities
52.0150.5152.3213.9814.71
Common Stock
0.040.040.040.040.03
Additional Paid-in Capital
103.6292.0881.1173.2866.22
Retained Earnings
-89.12-77.91-54.45-35.74-12.55
Total Common Shareholders' Equity
14.5414.2126.737.5853.7
Minority Interest
0.290.130.220.210.31
Shareholders' Equity
14.8314.3426.9237.7954.01
Total Liabilities & Equity
66.8464.8479.2451.7868.72
Total Debt
39.3438.7638.50.80.31
Net Cash (Debt)
-7.6-7.025.159.430.57
Net Cash Growth
---45.18%-69.26%-25.88%
Net Cash Per Share
-0.18-0.200.150.270.89
Book Value
14.5414.2126.737.5853.7
Book Value Per Share
0.350.400.771.091.56
Tangible Book Value
14.5414.2126.737.5853.7
Tangible Book Value Per Share
0.350.400.771.091.56
Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q